Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: The txt2heart Colombia randomised controlled trial protocol

Introduction Anti-platelet therapy, angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers, beta-blockers and statins are cost-effective in patients with atherosclerotic cardiovascular diseases (ASCVD) for reducing the risk of ASCVD events. Unfortunately, there is abundant evidenc...

Full description

Autores:

Bermon A.
Uribe-Rodríguez A.F.
Pérez-Rivero P.F.
Prieto-Merino D.
Cáceres Rivera, Diana Isabel
Guio E.
Atkins L.
Horne R.
Murray E.
Serrano Díaz N.C.
Free C.
Perel P.
Casas J.P.

Tipo de recurso:

Article of journal

Fecha de publicación:

2019

Institución:

Universidad Cooperativa de Colombia

Repositorio:

Repositorio UCC

Idioma:

OAI Identifier:

oai:repository.ucc.edu.co:20.500.12494/41786

Acceso en línea:

https://doi.org/10.1590/s0104-07072011000500010
https://hdl.handle.net/20.500.12494/41786

Palabra clave:

11 oxothromboxane B2
angiotensin receptor antagonist
atorvastatin
beta adrenergic receptor blocking agent
cardiovascular agent
dipeptidyl carboxypeptidase inhibitor
fluindostatin
hydroxymethylglutaryl coenzyme A reductase inhibitor
pravastatin
rosuvastatin
simvastatin
adult
Article
behavior change
blood
controlled study
coronary artery atherosclerosis
heart rate
human
low density lipoprotein cholesterol level
medication compliance
patient compliance
program efficacy
randomized controlled trial
secondary prevention
self report
single blind procedure
systolic blood pressure
text messaging

Rights

closedAccess

License

http://purl.org/coar/access_right/c_14cb